Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Oncology Letters
|
December 2, 2015
Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer
Zeki Gokhan Surmeli, Umut Varol, Burcu Cakar, et al.
Oncology Research and Treatment
|
October 10, 2015
The Role of Body Mass Index in Triple Negative Breast Cancer
Burcu Cakar, Ugur Muslu, Atike P Erdogan, et al.
Cancers
|
March 29, 2023
Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group
Izzet Dogan, Sercan Aksoy, Burcu Cakar, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 21, 2023
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study
Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, et al.
Cancers
|
February 13, 2026
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)
Sercan On, Selin Cebeci, Zeynep Hande Turna, et al.
Clinical Genitourinary Cancer
|
April 16, 2024
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)
Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, et al.
Cancer Cell
|
March 7, 2020
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer
Ze-Yi Zheng, Meenakshi Anurag, Jonathan T Lei, et al.
Medicine
|
May 24, 2024
A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy
Saadettin Kilickap, Akin Ozturk, Nuri Karadurmus, et al.
Anti-Cancer Drugs
|
June 15, 2022
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
Özlem Özdemir, Baha Zengel, Yaşar Yildiz, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Oncology Letters
|
December 2, 2015
Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer
Zeki Gokhan Surmeli, Umut Varol, Burcu Cakar, et al.
Oncology Research and Treatment
|
October 10, 2015
The Role of Body Mass Index in Triple Negative Breast Cancer
Burcu Cakar, Ugur Muslu, Atike P Erdogan, et al.
Cancers
|
March 29, 2023
Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group
Izzet Dogan, Sercan Aksoy, Burcu Cakar, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 21, 2023
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study
Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, et al.
Cancers
|
February 13, 2026
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)
Sercan On, Selin Cebeci, Zeynep Hande Turna, et al.
Clinical Genitourinary Cancer
|
April 16, 2024
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)
Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, et al.
Cancer Cell
|
March 7, 2020
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer
Ze-Yi Zheng, Meenakshi Anurag, Jonathan T Lei, et al.
Medicine
|
May 24, 2024
A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy
Saadettin Kilickap, Akin Ozturk, Nuri Karadurmus, et al.
Anti-Cancer Drugs
|
June 15, 2022
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
Özlem Özdemir, Baha Zengel, Yaşar Yildiz, et al.
Page
of 2